BTNL9 and thyroid gland disorder: It showed that BTNL9 expression was significantly associated with different clinical T stages, N stages, extrathyroidal extension, pathologic stages, histological types, primary neoplasm focus types, residual tumors, thyroid gland disorder history and disease progression (Fig. 4) in THCA patients.